Volume : 13, Issue : 06, June – 2026
Title:
ROLE OF CLINICAL PHARMACIST IN A HOSPITAL SETTING A COMPREHENSIVE REVIEW ARTICLE
Authors :
*Meghana Pendem , Neerudi Avinash, Marka Varshitha, Dr.D.Goutham
Abstract :
Background: 50 Years ago, clinical pharmacy looked nothing like it does now. Instead of just handing the medications, the field shifted focus toward caring for people. One big shift came when pharmacists moved into hospitals. There, they became key members of care teams. Because of their presence, treatment plans improved. Safety around medications strengthened too. Decisions about drugs started considering both results and expense. Their input helps balance effectiveness with spending. Patient outcomes took priority over old routines.
Objective: This review is a comprehensive analysis of the diverse roles of clinical pharmacists in different hospital departments and how they contribute to medication management, adverse drug reaction monitoring, patient counselling, antimicrobial stewardship, pharmacovigilance and clinical research
Methods: Through a narrative approach, sources emerged from searches in PubMed, Scopus, Google Scholar, along with WHO records. Trials assigned at random, forward-looking observation efforts, organized summaries, also official guidelines appearing from 2000 up to 2025 found their way into the pool. Topic fit decided inclusion – examples include pharmacists stepping in during hospital stays, clinic visits, or critical care moments.
Results: Medication mistakes happen less often when clinical pharmacists get involved. Better results from treatment pop up across many studies. Hospital stays tend to shrink because of their input. Costs in health care take a dip too. In antimicrobial programs, their role makes numbers shift in clear ways. Watching for drug side effects becomes more effective with them around. Managing long-term illnesses sees real changes thanks to their work. Different groups of patients show these gains plainly.
Conclusion: The contemporary hospital cannot do without clinical pharmacists. To ensure that they provide quality, safe, and equitable patient care, expanding their scope of practice, which is aided with strong policies and proper workforce planning, is crucial.
Keywords: Clinical pharmacist; hospital pharmacy; medication reconciliation; antimicrobial stewardship; pharmacovigilance; patient counselling; medication errors; pharmacy practice.
Cite This Article:
Please cite this article in press Meghana Pendem et al., Role Of Clinical Pharmacist In A Hospital Setting A Comprehensive Review Article.., Indo Am. J. P. Sci, 2026; 13(06).
REFERENCES:
1.Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–543.
2.World Health Organization. The Role of the Pharmacist in the Health Care System. Geneva: WHO; 1994. Available from: https://apps.who.int/iris/handle/10665/59373
3.World Health Organization. Medication Without Harm – WHO Global Patient Safety Challenge. Geneva: WHO; 2017.
4.Pharmacy Council of India. Pharm.D. Regulations 2008. New Delhi: PCI; 2008. Available from: http://www.pci.nic.in
5.Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management. 3rd ed. New York: McGraw-Hill; 2012.
6.International Pharmaceutical Federation (FIP). Clinical Pharmacy: Towards the Contribution in Health. The Hague: FIP; 2018.
7.Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP. 1990;24(11):1093–1097.
8.Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165(4):424–429.
9.Evans WE, McLeod HL. Pharmacogenomics — drug disposition, drug targets, and side effects. N Engl J Med. 2003;348(6):538–549.
10.National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). Taxonomy of Medication Errors. Rockville, MD: NCC MERP; 2001.
11.Khalil H, Huang C. Adverse drug reactions in primary care: a scoping review. BMC Health Serv Res. 2020;20:5.
12.Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–1205.
13.Central Drugs Standard Control Organisation (CDSCO). Pharmacovigilance Programme of India (PvPI). New Delhi: Ministry of Health and Family Welfare; 2010.
14.Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–e77.
15.Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2:CD003543.
16.American Society of Health-System Pharmacists (ASHP). ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health Syst Pharm. 1997;54(4):431–434.
17.Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes. Diabetes Care. 2012;35(12):2706–2717.
18.Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med. 1998;158(15):1641–1647.
19.Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–270.
20.Carrington C, Stone L, Tiley C, et al. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of systemic cancer therapy. Asia Pac J Clin Oncol. 2010;6(3):220–237.